Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diabetic neuropathies/slabost navzea

Povezava se shrani v odložišče
Stran 1 iz 45 rezultatov
To evaluate the efficacy and safety of 6 weeks of venlafaxine extended-release (ER) (75 mg and 150-225 mg) treatment in patients with painful diabetic neuropathy. This multicenter, double-blind, randomized, placebo-controlled study included 244 adult outpatients with metabolically stable type 1 or 2

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The effect of the selective serotonin reuptake inhibitor citalopram on diabetic neuropathy symptoms was examined in a double-blind, placebo-controlled, crossover study for two 3-week periods. Citalopram was given as a fixed dose of 40 mg/day. Data from 15 patients could be included in the

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at doses of 60 mg daily. Duloxetine has been shown to significantly improve the symptoms of chronic pain associated with these

Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE In patients with symptomatic diabetic polyneuropathy, is oral alpha-lipoic acid (ALA) effective in improving neuropathic symptoms compared with placebo? METHODS The question was addressed with a structured evidence-based clinical neurologic practice review via videoconferencing between 3

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE The objective of this study was to evaluate the efficacy and safety of tramadol in a 6-month open extension following a 6-week double-blind randomized trial. METHODS Patients with painful diabetic neuropathy who completed the double-blind study were eligible for enrollment in an open

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE The objective of this study was to evaluate the efficacy and safety of tramadol in treating the pain of diabetic neuropathy. BACKGROUND The pain of diabetic neuropathy is a major cause of morbidity among these patients and treatment, as with other small-fiber neuropathies, is often

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND Duloxetine hydrochloride is a reuptake inhibitor of 5-hydroxytryptamine and norepinephrine used to treat depression, generalized anxiety disorder, neuropathic pain, and stress incontinence in women. We investigated the efficacy of duloxetine in painful diabetic neuropathy and fibromyalgia

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Mexiletine is an orally active local anaesthetic agent which is structurally related to lidocaine (lignocaine) and has been used for alleviating neuropathic pain of various origins. Mexiletine has been evaluated in several randomised, placebo-controlled trials in patients with painful diabetic

Diabetic neuropathy in the gut: pathogenesis and diagnosis.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The activity of the digestive tract is usually regulated to match its content: physiological stimuli in the gut induce modulatory reflexes that control digestive function so that digestion is normally not perceived. However, under certain circumstances, digestive stimuli may activate sensory

Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND Factors associated with abdominal pain in gastroparesis are incompletely evaluated and comparisons of pain vs other symptoms are limited. This study related pain to clinical factors in gastroparesis and contrasted pain/discomfort- with nausea/vomiting-predominant disease. METHODS Clinical

Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Diabetic neuropathy is one of the most common long-term complications in patients with diabetes mellitus, with a prevalence of 60-70% in the United States. Treatment options include antidepressants, anticonvulsants, tramadol, and capsaicin. These agents are modestly effective for symptomatic relief,

Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The efficacy and tolerability of oral lacosamide (200, 400, and 600 mg/day) was evaluated in patients with painful diabetic neuropathy in a double-blind, randomized, placebo-controlled trial. The primary target dose to be confirmed was lacosamide 400 mg/day. Efficacy was assessed by changes in pain

Gangrenous cholecystitis: A silent but potential fatal disease in patients with diabetic neuropathy. A case report.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Gangrenous cholecystitis (GC) is a severe and potentially deadly complication of acute cholecystitis. We present a 83-year-old gentleman with a past medical history of type 2 diabetes mellitus with significant associated neuropathy, presenting to a community hospital in a major metropolitan area

Diabetic autonomic neuropathy causing gall bladder dysfunction.

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE The objective of the study was to study gall bladder volume in fasting and 45 minutes post-prandial, by real time ultrasound in healthy controls and diabetic patients with and without autonomic neuropathy and to compare them. METHODS Age, Sex and body mass index (BMI) matched 50 healthy
Nineteen diabetic patients with autonomic neuropathy were enrolled in a double-blind crossover study of cisapride, metoclopramide and placebo. Symptoms were evaluated from diary cards and from assessments undertaken at the end of each eight week treatment period. Measurements of oesophageal transit,
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge